Data as of Aug 29
| +0.22 / +3.84%|
The 1 analysts offering 12-month price forecasts for Enzo Biochem Inc have a median target of 5.50, with a high estimate of 5.50 and a low estimate of 5.50. The median estimate represents a -7.56% decrease from the last price of 5.95.
The current consensus among 1 polled investment analysts is to Buy stock in Enzo Biochem Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.